No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Wolters Kluwer Webinar Brings Together Nursing Leaders to Discuss New Technologies

Webinar will examine the influence of ChatGPT, generative AI and more on nursing education

Editor: What To Know

  • To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health, will host an online event titled, “Achieving academic excellence in nursing with new technologies.
  • The issues facing faculty and nursing students when it comes to using new technologies can seem overwhelming, so it is especially important to understand how generative AI could be used in developing research, EBP, and QI projects.
  • “In the midst of rapid adoption of AI-based technologies globally, a range of concerns ranging from academic integrity to plagiarism to misinformation has heightened the awareness among educators surrounding a need for action,” said Vikram Savkar, Senior Vice President &.

Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront. To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health, will host an online event titled, “Achieving academic excellence in nursing with new technologies: An Ovid® Synthesis webinar,” on Tuesday, June 13th from 2 to 3pm ET.

“In the midst of rapid adoption of AI-based technologies globally, a range of concerns ranging from academic integrity to plagiarism to misinformation has heightened the awareness among educators surrounding a need for action,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice at Wolters Kluwer Health. “The academic landscape must examine the best ways to benefit from these technologies while understanding the risks that may come with the implementation.”

The issues facing faculty and nursing students when it comes to using new technologies can seem overwhelming, so it is especially important to understand how generative AI could be used in developing research, EBP, and QI projects. In addition to the conversation around AI, the expert group will highlight how Ovid Synthesis can support a learning environment that promotes independent critical thinking and academic integrity.

The distinguished group of panelists that will discuss the oversight, guidance and support needed for academia facing this inflection point, includes:

  • Marilyn H. Oermann, PhD, RN, ANEF, FAAN, Thelma M. Ingles Professor of Nursing, Duke University School of Nursing; Editor-in-Chief, Nurse Educator
  • Grace H. Sun, MSN, NP, Associate Professor, Texas Tech University Health Sciences Center
  • Stephanie H. Hoelscher, DNP, RN-BC, CPHIMS, CHISP, FHIMSS, Associate Professor of Graduate Informatics and an Informatics Nurse Specialist, Texas Tech University Health Sciences Center
  • Shea Polancich, PhD, RN, Associate Professor and Assistant Dean, University of Alabama at Birmingham School of Nursing
  • (Host) Rachel Dicker, Product Management Associate Director, Wolters Kluwer, Health Learning, Research & Practice

Working in tandem with other groundbreaking technologies, Ovid Synthesis serves as a research repository, allowing all project information to be organized and stored in one simple solution, eliminating breakdowns and stalled projects. Learn more about how Ovid Synthesis can support your organization’s academic research challenges.

Wolters Kluwer Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy